Unità di Bioetica, Presidenza, Istituto Superiore di Sanità, Rome, Italy.
Ann Ist Super Sanita. 2012;48(2):119-21. doi: 10.4415/ANN_12_02_03.
Biological samples collected in biobanks are a resource with significant research potential. The Italian Joint Group CNB - CNBBSV (National Committee of Bioethics - National Committee for Biosecurity, Biotechnologies and Life Sciences) published a document reporting recommendations on storage and use of dried blood spot (DBS) and on the development of a National Network of Regional Newborn Screening Repositories for collection of residual DBS. Several ethical questions (about consent, possible use of genetic information, unanticipated possible usages for research purposes) rise from residual newborn screening specimens collections. Moreover, legal and ethical controversies are accentuated by the conflicts between the interests of sample donors, biobank holders, researchers and the public. To overcome these difficulties the identification of a few criteria for storage and research usage of DBS is crucial.
生物样本库中收集的生物样本是具有重要研究潜力的资源。意大利联合 CNB-CNBBSV 小组(国家生物伦理委员会-国家生物安全、生物技术和生命科学委员会)发布了一份报告,其中提出了关于储存和使用干血斑(DBS)的建议,并制定了一个国家新生儿筛查储存库网络,用于收集剩余的 DBS。从剩余的新生儿筛查标本收集中产生了几个伦理问题(关于同意、遗传信息的可能使用、研究目的的意外可能用途)。此外,样本捐赠者、生物库持有者、研究人员和公众的利益之间的冲突加剧了法律和伦理方面的争议。为了克服这些困难,确定 DBS 的储存和研究使用的一些标准是至关重要的。